Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
International plans for Telix – proudly boasting its intentions to list on the NASDAQ for a while now – have come to an anticlimactic end.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results